Skip to main content
Research project

Sean Lim - CELLDEX -RAVE - CRUK (NAC) and Celldex : A phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies (RAVE study).

Research areas:
Research groups:
Lead researcher:
Other researchers:
Research funder:
Celldex Therapeutics Inc
Status:
Active
Back to top